No Data
YUE DA INTL (00629.HK) plans to acquire equity in Chengdu Nuoyide Medical Laboratory.
On April 29, Gelonghui announced that YUE DA INTL (00629.HK) signed a non-binding term sheet with Chengdu Nuoyide Medical Testing Laboratory Co., Ltd. (the target company) and Shenzhen Jingke Biotechnology Co., Ltd. (the seller) on April 30, 2025, under which the company intends to (a) acquire 30% of the equity of the target company through an investment of approximately RMB 30,000,000, and (b) purchase 22% of the equity of the target company from the seller for approximately RMB 22,000,000. Once the potential acquisition is completed, the target company will become a non-wholly owned subsidiary of the company.
Express News | Yue Da International - to Acquire 30% Stake in Chengdu Organoidmed Medical Laboratory by Capital Injection of RMB30 Mln
Express News | Yue Da International - Entered Into Non- Legal Binding Term Sheet With Chengdu Organoidmed Medical Laboratory and Shenzhen Jingke Biotechnology
YUE DA INTL: Annual Report 2024
YUE DA INTL (00629.HK) subsidiary YUE DA Commercial Factoring has entered into a factoring agreement with Yancheng Lianyang.
On March 26, Gelonghui reported that YUE DA INTL (00629.HK) announced that on March 26, 2025, its indirect wholly-owned subsidiary YUE DA Commercial Factoring entered into a factoring agreement with Yancheng Lianyang. According to the factoring agreement, YUE DA Commercial Factoring agrees to provide accounts receivable financing, accounts receivable management services, and accounts receivable collection services to Yancheng Lianyang and grants a revolving credit limit of 45 million RMB, with a combined interest rate and factoring management fee ranging from 8.2% to 9.2%, effective from March 26, 2025 and expiring on April 1, 2027.
YUE DA INTL (00629.HK) annual profit reached 16.46 million yuan with a final dividend of 0.46 Hong Kong cents.
On March 20, Gelonghui announced that YUE DA INTL (00629.HK) reported that for the year ending December 31, 2024, the group's factoring business recorded operating income of RMB 63,852,000 (last year: RMB 88,487,000). The profit attributable to shareholders and total comprehensive income increased from RMB 15,192,000 last year to RMB 16,458,000 this year. The company's Directors proposed a final dividend of HKD 0.46 per ordinary share (2023: HKD 0.43).
Investors Still Aren't Entirely Convinced By Yue Da International Holdings Limited's (HKG:629) Earnings Despite 37% Price Jump
